Literature DB >> 25349046

Mucus as a barrier to drug delivery – understanding and mimicking the barrier properties.

Marie Boegh1, Hanne Mørck Nielsen.   

Abstract

Viscoelastic mucus lines all mucosal surfaces of the body and forms a potential barrier to mucosal drug delivery. Mucus is mainly composed of water and mucins; high molecular weight glycoproteins forming an entangled network. Consequently, mucus forms a steric barrier, and due to its negative charge and hydrophobic domains, the overall hydrophilic mucus also presents an interactive barrier limiting the free diffusion of components within and through the mucus. Furthermore, mucus is a dynamic barrier due to its continuous secretion and shedding from the mucosal surfaces. Mucus is thus a highly complex gel barrier to drug delivery. Current knowledge of mucus characteristics and barrier properties, as achieved by state-of-the-art methodologies, is the topic of this MiniReview emphasizing the gastrointestinal mucus and an overall focus on oral drug delivery. Cell culture-based in vitro models are well-established as essential tools in drug research and development, but traditionally, mucus-containing models have only rarely been applied. However, a number of mucus-containing in vitro models have recently been described in the literature, and their properties and applications will be reviewed and discussed. Finally, studies of peptide and protein drug diffusion in and through mucus and studies of mucus-penetrating nanoparticles are included to illustrate the mucus as a potentially important barrier to obtain sufficient bioavailability of orally administered drugs, and thus an important parameter to address in the development of future oral drug delivery systems.
© 2014 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25349046     DOI: 10.1111/bcpt.12342

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  42 in total

Review 1.  Bile acid transporter-mediated oral drug delivery.

Authors:  Feiyang Deng; You Han Bae
Journal:  J Control Release       Date:  2020-07-22       Impact factor: 9.776

2.  New model tackles sticky problem of getting drugs past mucus.

Authors:  Juhie Bhatia
Journal:  Nat Med       Date:  2015-04       Impact factor: 53.440

3.  A Model for the Transient Subdiffusive Behavior of Particles in Mucus.

Authors:  Matthias Ernst; Thomas John; Marco Guenther; Christian Wagner; Ulrich F Schaefer; Claus-Michael Lehr
Journal:  Biophys J       Date:  2017-01-10       Impact factor: 4.033

Review 4.  Getting Drugs Across Biological Barriers.

Authors:  Rong Yang; Tuo Wei; Hannah Goldberg; Weiping Wang; Kathleen Cullion; Daniel S Kohane
Journal:  Adv Mater       Date:  2017-07-28       Impact factor: 30.849

5.  Probing mucin interaction behavior of magnetic nanoparticles.

Authors:  Vijayakumar N Boya; Renn Lovett; Saini Setua; Vaibhav Gandhi; Prashanth K B Nagesh; Sheema Khan; Meena Jaggi; Murali M Yallapu; Subhash C Chauhan
Journal:  J Colloid Interface Sci       Date:  2016-11-01       Impact factor: 8.128

6.  Disease Models: Lung Models for Testing Drugs Against Inflammation and Infection.

Authors:  Patrick Carius; Justus C Horstmann; Cristiane de Souza Carvalho-Wodarz; Claus-Michael Lehr
Journal:  Handb Exp Pharmacol       Date:  2021

7.  Human intestinal enteroids as a model of Clostridioides difficile-induced enteritis.

Authors:  Melinda A Engevik; Heather A Danhof; Alexandra L Chang-Graham; Jennifer K Spinler; Kristen A Engevik; Beatrice Herrmann; Bradley T Endres; Kevin W Garey; Joseph M Hyser; Robert A Britton; James Versalovic
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-03-30       Impact factor: 4.052

8.  In Vitro Intestinal Uptake And Permeability Of Fluorescently-Labelled Hyaluronic Acid Nanogels.

Authors:  Miguel Xavier; Lorena García-Hevia; Isabel R Amado; Lorenzo Pastrana; Catarina Gonçalves
Journal:  Int J Nanomedicine       Date:  2019-11-21

9.  Effective Antitumor of Orally Intestinal Targeting Penetrating Peptide-Loaded Tyroserleutide/PLGA Nanoparticles in Hepatocellular Carcinoma.

Authors:  Chenjun Ma; Tiantian Wei; Yingying Hua; Zhongjie Wang; Liefeng Zhang
Journal:  Int J Nanomedicine       Date:  2021-07-02

10.  Oral delivery of metformin by chitosan nanoparticles for polycystic kidney disease.

Authors:  Jonathan Wang; Deborah Chin; Christopher Poon; Valeria Mancino; Jessica Pham; Hui Li; Pei-Yin Ho; Kenneth R Hallows; Eun Ji Chung
Journal:  J Control Release       Date:  2020-10-28       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.